{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:46:09Z","timestamp":1789757169721,"version":"4.0.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin Municipality","doi-asserted-by":"publisher","award":["24JCYBJC00620"],"award-info":[{"award-number":["24JCYBJC00620"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin Municipality","doi-asserted-by":"publisher","award":["23JCQNJC00290"],"award-info":[{"award-number":["23JCQNJC00290"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010041","name":"Tianjin Municipal Science and Technology Committee","doi-asserted-by":"publisher","award":["TJWJ2025QN029"],"award-info":[{"award-number":["TJWJ2025QN029"]}],"id":[{"id":"10.13039\/501100010041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017964","name":"Tianjin Municipal Health Commission","doi-asserted-by":"publisher","award":["TJYXZDXK-009A"],"award-info":[{"award-number":["TJYXZDXK-009A"]}],"id":[{"id":"10.13039\/100017964","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2025ZD0552400\/2025ZD0552406"],"award-info":[{"award-number":["2025ZD0552400\/2025ZD0552406"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015406","name":"Tianjin Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["2024KJ173"],"award-info":[{"award-number":["2024KJ173"]}],"id":[{"id":"10.13039\/501100015406","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010882","name":"Tianjin Municipal Education Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010882","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M742619"],"award-info":[{"award-number":["2023M742619"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M772011"],"award-info":[{"award-number":["2025M772011"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82505095"],"award-info":[{"award-number":["82505095"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82503335"],"award-info":[{"award-number":["82503335"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271895"],"award-info":[{"award-number":["82271895"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303281"],"award-info":[{"award-number":["82303281"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573121"],"award-info":[{"award-number":["82573121"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.drup.2026.101385","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T20:38:04Z","timestamp":1772483884000},"page":"101385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The c-Myc-USP14-PFKP axis sustains chemoresistance in pancreatic ductal adenocarcinoma"],"prefix":"10.1016","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8878-7191","authenticated-orcid":false,"given":"Pengyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaozhe","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhua","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danqi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.drup.2026.101385_bib1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41392-023-01705-z","article-title":"Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies","volume":"8","author":"Bahar","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.drup.2026.101385_bib2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1158\/2159-8290.CD-12-0018","article-title":"Negative feedback and adaptive resistance to the targeted therapy of cancer","volume":"2","author":"Chandarlapaty","year":"2012","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.drup.2026.101385_bib3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41392-025-02546-8","article-title":"Glycolytic heterogeneity drives metabolic-targeted therapy in pancreatic ductal adenocarcinoma","volume":"11","author":"Chianese","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"issue":"6","key":"10.1016\/j.drup.2026.101385_bib4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41580-019-0099-1","article-title":"Breaking the chains: deubiquitylating enzyme specificity begets function","volume":"20","author":"Clague","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.drup.2026.101385_bib5","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2017.04.023","article-title":"The logic of the 26S proteasome","volume":"169","author":"Collins","year":"2017","journal-title":"Cell"},{"issue":"32","key":"10.1016\/j.drup.2026.101385_bib6","doi-asserted-by":"crossref","first-page":"E4410","DOI":"10.1073\/pnas.1501605112","article-title":"Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors","volume":"112","author":"Daemen","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.drup.2026.101385_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12943-025-02285-y","article-title":"NNMT promotes acquired EGFR-TKI resistance by forming EGR1 and lactate-mediated double positive feedback loops in non-small cell lung cancer","volume":"24","author":"Dai","year":"2025","journal-title":"Mol. Cancer"},{"issue":"21","key":"10.1016\/j.drup.2026.101385_bib8","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.1158\/1078-0432.CCR-09-0889","article-title":"MYC-induced cancer cell energy metabolism and therapeutic opportunities","volume":"15","author":"Dang","year":"2009","journal-title":"Clin. Cancer Res. Official Journal American Association Cancer Research"},{"issue":"1","key":"10.1016\/j.drup.2026.101385_bib9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","article-title":"MYC on the path to cancer","volume":"149","author":"Dang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.drup.2026.101385_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102154","article-title":"MYC as a target for cancer treatment","volume":"94","author":"Duffy","year":"2021","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.drup.2026.101385_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115647","article-title":"Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies","volume":"224","author":"du Toit-Thompson","year":"2025","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.drup.2026.101385_bib12","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a014365","article-title":"MYC degradation","volume":"4","author":"Farrell","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.drup.2026.101385_bib13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.semcancer.2020.11.008","article-title":"Epigenetic modifications of c-MYC: role in cancer cell reprogramming, progression and chemoresistance","volume":"83","author":"Fatma","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"8","key":"10.1016\/j.drup.2026.101385_bib14","first-page":"599","article-title":"Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma","volume":"20","author":"Fu","year":"2023","journal-title":"Cancer Biol. Med."},{"issue":"1","key":"10.1016\/j.drup.2026.101385_bib15","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12943-024-02005-y","article-title":"Drug resistance mechanisms and treatment strategies mediated by Ubiquitin-Specific Proteases (USPs) in cancers: new directions and therapeutic options","volume":"23","author":"Gao","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.drup.2026.101385_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ccell.2016.12.006","article-title":"Employing metabolism to improve the diagnosis and treatment of pancreatic cancer","volume":"31","author":"Halbrook","year":"2017","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.drup.2026.101385_bib17","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","article-title":"Pancreatic cancer: advances and challenges","volume":"186","author":"Halbrook","year":"2023","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.drup.2026.101385_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrd.2017.152","article-title":"Deubiquitylating enzymes and drug discovery: emerging opportunities","volume":"17","author":"Harrigan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.drup.2026.101385_bib19","first-page":"63","article-title":"IL6-STAT3-C\/EBP\u03b2-IL6 positive feedback loop in tumor-associated macrophages promotes the EMT and metastasis of lung adenocarcinoma","volume":"43","author":"Hu","year":"2024","journal-title":"J. Exper. Clin. Cancer Res. CR"},{"issue":"11","key":"10.1016\/j.drup.2026.101385_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113426","article-title":"p53-responsive CMBL reprograms glucose metabolism and suppresses cancer development by destabilizing phosphofructokinase PFKP","volume":"42","author":"Huang","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.drup.2026.101385_bib21","article-title":"TRIM29 facilitates gemcitabine resistance via MEK\/ERK pathway and is modulated by circRPS29\/miR-770-5p axis in PDAC","volume":"74","author":"Huang","year":"2024","journal-title":"Drug Resist. Update. Rev. Comment. Antimicrob. Anticancer Chemother."},{"issue":"2","key":"10.1016\/j.drup.2026.101385_bib22","article-title":"KRASG12D-driven pentose phosphate pathway remodeling imparts a targetable vulnerability synergizing with MRTX1133 for durable remissions in PDAC","volume":"6","author":"Jiang","year":"2025","journal-title":"Cell Rep. Med."},{"issue":"5","key":"10.1016\/j.drup.2026.101385_bib23","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrc3038","article-title":"Otto Warburg's contributions to current concepts of cancer metabolism","volume":"11","author":"Koppenol","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"19","key":"10.1016\/j.drup.2026.101385_bib24","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.3390\/ijms21197304","article-title":"A perspective on therapeutic pan-resistance in metastatic cancer","volume":"21","author":"Korentzelos","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"7312","key":"10.1016\/j.drup.2026.101385_bib25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature09299","article-title":"Enhancement of proteasome activity by a small-molecule inhibitor of USP14","volume":"467","author":"Lee","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.drup.2026.101385_bib26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s10020-024-00892-x","article-title":"Targeting AGTPBP1 inhibits pancreatic cancer progression via regulating microtubules and ERK signaling pathway","volume":"30","author":"Li","year":"2024","journal-title":"Mol. Med."},{"issue":"10","key":"10.1016\/j.drup.2026.101385_bib27","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/s41419-024-07138-y","article-title":"cNEK6 induces gemcitabine resistance by promoting glycolysis in pancreatic ductal adenocarcinoma via the SNRPA\/PPA2c\/mTORC1 axis","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.drup.2026.101385_bib28","article-title":"Metabolic classification suggests the GLUT1\/ALDOB\/G6PD axis as a therapeutic target in chemotherapy-resistant pancreatic cancer","volume":"4","author":"Li","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"8","key":"10.1016\/j.drup.2026.101385_bib29","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/s41419-024-06946-6","article-title":"M6A-methylated circPOLR2B forms an R-loop and regulates the biological behavior of glioma stem cells through positive feedback loops","volume":"15","author":"Lin","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drup.2026.101385_bib30","article-title":"Targeting cTRIP12 counteracts ferroptosis resistance and augments sensitivity to immunotherapy in pancreatic cancer","volume":"81","author":"Lin","year":"2025","journal-title":"Drug Resist. Update. Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.drup.2026.101385_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116875","article-title":"Emerging role of ubiquitin-specific protease 14 in oncogenesis and development of tumor: therapeutic implication","volume":"239","author":"Liu","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.drup.2026.101385_bib32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.canlet.2020.11.023","article-title":"SETD8 potentiates constitutive ERK1\/2 activation via epigenetically silencing DUSP10 expression in pancreatic cancer","volume":"499","author":"Liu","year":"2021","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.drup.2026.101385_bib33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12943-024-02051-6","article-title":"A positive feedback loop between PFKP and c-Myc drives head and neck squamous cell carcinoma progression","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.drup.2026.101385_bib34","doi-asserted-by":"crossref","first-page":"7323","DOI":"10.1038\/s41467-024-51808-6","article-title":"Structural basis for allosteric regulation of human phosphofructokinase-1","volume":"15","author":"Lynch","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.drup.2026.101385_bib35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1158\/1078-0432.CCR-19-2926","article-title":"Metabolic Subtyping for Novel Personalized Therapies Against Pancreatic Cancer","volume":"26","author":"Mehla","year":"2020","journal-title":"Clin. Cancer Res. Official J. American Association Cancer Research"},{"key":"10.1016\/j.drup.2026.101385_bib36","article-title":"Post-translational modifications in drug resistance","volume":"78","author":"Miao","year":"2025","journal-title":"Drug Resist. Update. Rev. Comment. Antimicrob. Anticancer Chemother."},{"issue":"1","key":"10.1016\/j.drup.2026.101385_bib37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ccell.2023.12.002","article-title":"EGFR-activated myofibroblasts promote metastasis of pancreatic cancer","volume":"42","author":"Mucciolo","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2026.101385_bib38","article-title":"Cancer plasticity in therapy resistance: mechanisms and novel strategies","volume":"76","author":"Niu","year":"2024","journal-title":"Drug Resist. Update. Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.drup.2026.101385_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2025.108946","article-title":"Molecular, metabolic, and histological subtypes of pancreatic ductal adenocarcinoma and its tumor microenvironment: insights into tumor heterogeneity and clinical implications","volume":"277","author":"Ohara","year":"2026","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.drup.2026.101385_bib40","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/ijc.34960","article-title":"ELAPOR1 induces the classical\/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancer","volume":"155","author":"Ohara","year":"2024","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.drup.2026.101385_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2022.101097","article-title":"Pathological implication of protein post-translational modifications in cancer","volume":"86","author":"Pan","year":"2022","journal-title":"Mol. Asp. Med."},{"issue":"19","key":"10.1016\/j.drup.2026.101385_bib42","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1038\/s41388-020-1255-y","article-title":"Feedback analysis identifies a combination target for overcoming adaptive resistance to targeted cancer therapy","volume":"39","author":"Park","year":"2020","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.drup.2026.101385_bib43","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","article-title":"The hallmarks of cancer metabolism: Still emerging","volume":"34","author":"Pavlova","year":"2022","journal-title":"Cell Metab."},{"issue":"8","key":"10.1016\/j.drup.2026.101385_bib44","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s43018-023-00595-y","article-title":"Cancer cell plasticity during tumor progression, metastasis and response to therapy","volume":"4","author":"P\u00e9rez-Gonz\u00e1lez","year":"2023","journal-title":"Nat. Cancer"},{"issue":"1","key":"10.1016\/j.drup.2026.101385_bib45","doi-asserted-by":"crossref","first-page":"17399","DOI":"10.1038\/s41598-023-43982-2","article-title":"PFKP is a prospective prognostic, diagnostic, immunological and drug sensitivity predictor across pan-cancer","volume":"13","author":"Peng","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.drup.2026.101385_bib46","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13045-020-00958-3","article-title":"Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma","volume":"13","author":"Qian","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.drup.2026.101385_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215763","article-title":"LncRNAs driving feedback loops to boost drug resistance: sinuous pathways in cancer","volume":"543","author":"S\u00e1nchez-Mar\u00edn","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2026.101385_bib48","article-title":"Unveiling the resistance to therapies in pancreatic ductal adenocarcinoma","volume":"77","author":"Shah","year":"2024","journal-title":"Drug Resist. Update. Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.drup.2026.101385_bib49","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-031621-024600","article-title":"Tumor microenvironment in pancreatic cancer pathogenesis and therapeutic resistance","volume":"18","author":"Sherman","year":"2023","journal-title":"Annu. Rev. Pathol."},{"issue":"7","key":"10.1016\/j.drup.2026.101385_bib50","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s40265-020-01304-0","article-title":"New treatment strategies for metastatic pancreatic ductal adenocarcinoma","volume":"80","author":"Singh","year":"2020","journal-title":"Drugs"},{"issue":"18","key":"10.1016\/j.drup.2026.101385_bib51","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"New Engl. J. Med."},{"issue":"5","key":"10.1016\/j.drup.2026.101385_bib52","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1002\/jcp.30124","article-title":"Ubiquitin-specific protease 14 is a new therapeutic target for the treatment of diseases","volume":"236","author":"Wang","year":"2021","journal-title":"J. Cell. Physiol."},{"issue":"8","key":"10.1016\/j.drup.2026.101385_bib53","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.3390\/cancers15082385","article-title":"The ubiquitin-proteasome system in tumor metabolism","volume":"15","author":"Wang","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.drup.2026.101385_bib54","first-page":"149","article-title":"Novel Pt@PCN-Cu-induced cuproptosis amplifies \u03b1PD-L1 immunotherapy in pancreatic ductal adenocarcinoma through mitochondrial HK2-mediated PD-L1 upregulation","volume":"44","author":"Wang","year":"2025","journal-title":"J. Exper. Clin.Cancer Res. CR"},{"issue":"12","key":"10.1016\/j.drup.2026.101385_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70036","article-title":"Deubiquitinases as novel therapeutic targets for diseases","volume":"5","author":"Xian","year":"2024","journal-title":"MedComm"},{"issue":"22","key":"10.1016\/j.drup.2026.101385_bib56","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1158\/0008-5472.CAN-21-0281","article-title":"LncRNA HIF1A-AS1 promotes gemcitabine resistance of pancreatic cancer by enhancing glycolysis through modulating the AKT\/YB1\/HIF1\u03b1 pathway","volume":"81","author":"Xu","year":"2021","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.drup.2026.101385_bib57","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41556-024-01349-3","article-title":"SHP-1 inhibition targets leukaemia stem cells to restore immunosurveillance and enhance chemosensitivity by metabolic reprogramming","volume":"26","author":"Xu","year":"2024","journal-title":"Nat. Cell Biol."},{"issue":"3","key":"10.1016\/j.drup.2026.101385_bib58","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","article-title":"Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism","volume":"149","author":"Ying","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.drup.2026.101385_bib59","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1186\/s12967-025-06897-2","article-title":"Phosphofructokinase-1 redefined: a metabolic hub orchestrating cancer hallmarks through multi-dimensional control networks","volume":"23","author":"Yuan","year":"2025","journal-title":"J. Transl. Med."},{"issue":"7","key":"10.1016\/j.drup.2026.101385_bib60","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1158\/2159-8290.CD-19-0015","article-title":"Cellular Plasticity in Cancer","volume":"9","author":"Yuan","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.drup.2026.101385_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2025.101368","article-title":"Metabolic reprogramming of drug resistance in pancreatic cancer: mechanisms and effects","volume":"103","author":"Zhang","year":"2025","journal-title":"Mol. Asp. Med."},{"issue":"1","key":"10.1016\/j.drup.2026.101385_bib62","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.1038\/s41467-023-40727-7","article-title":"Single cell transcriptomic analyses implicate an immunosuppressive tumor microenvironment in pancreatic cancer liver metastasis","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2026.101385_bib63","article-title":"NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degradation of MHC-1","volume":"73","author":"Zhang","year":"2024","journal-title":"Drug Resist. Update. Rev. Comment. Antimicrob. Anticancer Chemother."}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626000361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626000361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T23:29:32Z","timestamp":1781825372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764626000361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":63,"alternative-id":["S1368764626000361"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2026.101385","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The c-Myc-USP14-PFKP axis sustains chemoresistance in pancreatic ductal adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2026.101385","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101385"}}